Skip to main content

News

Respiratory viruses, vaccines, and the heart: lessons from DANFLU-2, DAN-RSV, and beyond

This editorial refers to ‘High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease....

Read the full editorial (European Heart Journal (2025) 46, 4299–4301) here!

PCSK9 reloaded: sirtuin-1 as a post-translational checkpoint for LDL-C control

This editorial refers to ‘Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation’ by S. Velagapudi et al.

Read the full editorial (Cardiovascular Research (2025) 121, 1306–1307) here!

AI-enhanced management of heart attack patients: a precision medicine approach

Care for patients with non-ST-elevation acute coronary syndrome (NSTE-ACS), the most common type of heart attack, is guided by the Global Registry of Acute Coronary Events (GRACE) score. However, it has long been recognised that current management stratification cannot fully capture the complexity of these patients.

Read the free full-text article here!

ESC 2025 Interview: Florian A. Wenzl - How can AI transform cardiology?

How can AI transform cardiology? Florian A. Wenzl from the ESC Digital Cardiology and AI Committee shares insights on GRACE 3.0, precision diagnostics, and the barriers and opportunities in bringing AI into everyday clinical practice

Read the interview here!

World Heart Day 2025

📢 September 29th is the World Heart Day 2025!!! 📢 
💗 DON'T MISS A BEAT 💗 
Join the World Heart Federation's mission to make every heartbeat count, with better heart health and improved access to life-saving care. 

Learn more here!

The micobiome is the new risk factor: and Imidazole Proprionate (IMP) is the new kid on the block - Short InsideCardiology Video

A new study, published in the European Heart Journal, establishes imidazole propionate (ImP), a gut microbiota-derived molecular driver of vascular inflammation and atherosclerosis, as a novel nontraditional cardiovascular risk factor in patients with coronary artery disease.

Watch the short video & get the full article here!
Subscribe to InsideCardiology here!

Shaping the future on a solid tradition - ESC President’s Page

This August, the European Society of Cardiology (ESC) celebrates its 75th birthday....The first ESC Congress was organized in London in September 1952 by Sir John Parkinson—75 years is quite an achievement for a learning society such as the ESC and demonstrates that it is here to stay.

Read full ESC President’s Page (European Heart Journal (2025) 00, 1–4) here

Cardiovascular System | 2025 Edition Textbook

Editors:  Thomas F. Lüscher, Ulf Landmesser

  • A complete organ system from anatomy to therapy
  • Learning in the module - All-around carefree through cardiology
  • For medical students and doctors in training and further education

Get it here!

European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice

Hypertension is the most prevalent modifiable risk factor for cardiovascular disease. This Expert Recommendation, highlights the key consensus recommendations from two guidelines & aim to help health­care professionals.

Read full article (July 2025 Nature Reviews Cardiology) here